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ABSTRACT
We have investigated factors that influence the production of native-like soluble, recombinant trimers based on the env genes of
two isolates of human immunodeficiency virus type 1 (HIV-1), specifically 92UG037.8 (clade A) and CZA97.012 (clade C). When
the recombinant trimers based on the env genes of isolates 92UG037.8 and CZA97.012 were made according to the SOSIP.664
design and purified by affinity chromatography using broadly neutralizing antibodies (bNAbs) against quaternary epitopes
(PGT145 and PGT151, respectively), the resulting trimers are highly stable and they are fully native-like when visualized by neg-
ative-stain electron microscopy. They also have a native-like (i.e., abundant) oligomannose glycan composition and display mul-
tiple bNAb epitopes while occluding those for nonneutralizing antibodies. In contrast, uncleaved, histidine-tagged Foldon (Fd)
domain-containing gp140 proteins (gp140UNC-Fd-His), based on the same env genes, very rarely form native-like trimers, a find-
ing that is consistent with their antigenic and biophysical properties and glycan composition. The addition of a 20-residue flexi-
ble linker (FL20) between the gp120 and gp41 ectodomain (gp41ECTO) subunits to make the uncleaved 92UG037.8 gp140-FL20
construct is not sufficient to create a native-like trimer, but a small percentage of native-like trimers were produced when an
I559P substitution in gp41ECTO was also present. The further addition of a disulfide bond (SOS) to link the gp120 and gp41 sub-
units in the uncleaved gp140-FL20-SOSIP protein increases native-like trimer formation to 20 to 30%. Analysis of the disulfide
bond content shows that misfolded gp120 subunits are abundant in uncleaved CZA97.012 gp140UNC-Fd-His proteins but very
rare in native-like trimer populations. The design and stabilization method and the purification strategy are, therefore, all im-
portant influences on the quality of trimeric Env proteins and hence their suitability as vaccine components.
IMPORTANCE
Soluble, recombinant multimeric proteins based on the HIV-1 env gene are current candidate immunogens for vaccine trials in
humans. These proteins are generally designed to mimic the native trimeric envelope glycoprotein (Env) that is the target of vi-
rus-neutralizing antibodies on the surfaces of virions. The underlying hypothesis is that an Env-mimetic protein may be able to
induce antibodies that can neutralize the virus broadly and potently enough for a vaccine to be protective. Multiple different
designs for Env-mimetic trimers have been put forth. Here, we used the CZA97.012 and 92UG037.8 env genes to compare some
of these designs and determine which ones best mimic virus-associated Env trimers. We conclude that the most widely used ver-
sions of CZA97.012 and 92UG037.8 oligomeric Env proteins do not resemble the trimeric Env glycoprotein on HIV-1 viruses,
which has implications for the design and interpretation of ongoing or proposed clinical trials of these proteins.
Recombinant, soluble envelope glycoprotein (Env) gp140 trim-ers from human immunodeficiency virus type 1 (HIV-1) are
being designed, developed, and produced as vaccine candidates
intended to induce neutralizing antibody (NAb) responses (1–8).
In general, the goal of trimer design projects is to produce proteins
that can be expressed and purified in sufficient quantities for vac-
cine use while retaining as closely as possible a conformation that
mimics functional Env on the surfaces of virus particles. There,
Env trimers mediate virus entry into target cells by undergoing a
complex and coordinated series of receptor-mediated conforma-
tional changes and rearrangements in their gp120 and gp41 sub-
units that drive the fusion of the viral and cell membranes (9, 10).
The fact that they must undergo such structural alterations means
that HIV-1 Env trimers are metastable; the constituent subunits
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are associated via noncovalent interactions that can be disrupted
fairly easily, for example by detergents or modestly elevated tem-
peratures (11, 12). That inherent instability has repercussions
when recombinant versions are made as soluble proteins for
vaccine research. Thus, the truncations necessary to produce
soluble gp140 proteins (gp140s), which eliminate the mem-
brane-spanning and cytoplasmic domains, further destabilize
the trimers such that they disintegrate into the constituent
gp120 and gp41 ectodomain (gp41ECTO) components.
It is important that recombinant trimers retain a native-like
structure because they are intended to raise NAbs that recognize
the functional Env trimer on the virus, and hence inhibit virus
infection. Although nonnative forms of Env can induce NAbs
against neutralization-sensitive viruses (tier 1 classification), they
have not been able to raise antibodies that neutralize the more-
resistant variants (tier 2 or 3) that are transmitted between people
(2, 4, 5, 13–16). As the paramount goal of most current Env vac-
cine design strategies is to induce antibodies that possess both
potency against tier 2 viruses and breadth against many circulat-
ing HIV-1 strains, advances are needed. It can be hypothesized,
and now shown, that native-like Env trimers constitute such a step
forward by better presenting key epitopes for broadly neutralizing
antibodies (bNAbs) that recognize properly folded and assembled
quaternary structures (1, 8, 17–26). How, then, can such native-
like trimers be produced and purified most easily? Clearly, this
cannot happen without introducing sequence modifications that
improve trimer stability.
One successful stabilization strategy involves facilitating the
natural cleavage of gp140 into gp120 and gp41ECTO, creating an
intrasubunit disulfide bond (designated SOS) to covalently link
the two subunits, and inserting a point substitution, I559P, into
gp41ECTO to maintain the trimer in its prefusion form. The result-
ing, cleaved, soluble trimers, designated SOSIP.664, when based
on a subset of env genes such as BG505 and B41, retain native-like
structure as assessed by multiple criteria (11, 18, 19, 21, 22, 25–
30). An alternative approach widely used over the past 20 years has
been to eliminate the natural cleavage site between gp120 and
gp41ECTO, such that the two subunits remain covalently linked.
Often, a trimerization domain is added to the C terminus of
gp41ECTO, most commonly a Foldon (Fd) moiety (2, 4, 14, 15,
30–34). The resulting uncleaved gp140 (gp140UNC) proteins can
be purified as entities that contain three gp120 subunits and three
gp41ECTO subunits (2, 4, 14, 15, 32–36). However, a variety of
assays show that these gp140UNC proteins do not adopt or retain a
native-like structure (19, 30, 33, 37–39). Instead, they represent
semidisintegrated trimers in which the uncleaved peptide linking
the gp120 and gp41ECTO subunits holds the components together
in a disordered fashion (19, 30, 33, 37–41). Recent reports show
that this defect can be at least partially overcome for some Env
genotypes by introducing a flexible linker between the C terminus
of gp120 and the N terminus of gp41ECTO, such that the two sub-
units remain covalently linked but now in a way that allows them
to interact properly (3, 7). When the I559P substitution is also
present, the resulting uncleaved gp140s trimerize and now can
adopt a native-like structure that is broadly comparable to those of
cleaved SOSIP.664 trimers (3, 7). Addition of the SOS intermo-
lecular disulfide bond confers additional benefit (7). These un-
cleaved, native-like trimers have been designated single-chain
gp140 (sc-gp140) or native flexibly linked gp140 (NFL-gp140)
(3, 7).
It has been claimed, however, that the introduction of a 20-
residue flexible linker (FL20), without any further modification, is
sufficient to make fully native-like uncleaved 92UG037.8 gp140-
FL20 trimers and that the latter proteins are, in practice, structur-
ally and biophysically comparable to both gp140UNC proteins of
the standard design and to cleaved BG505 SOSIP.664 trimers (42).
We have, therefore, explored the basis of these claims by making
gp140UNC proteins, with and without a flexible linker, and com-
paring them to SOSIP.664 trimers made from the same env genes,
92UG037.8 and CZA97.012 from clades A and C, respectively. We
studied the resulting Env proteins in multiple assay systems, in-
cluding surface plasmon resonance (SPR), negative-stain electron
microscopy (EM), differential scanning calorimetry (DSC), gly-
can composition analysis, hydrogen/deuterium exchange mass
spectrometry (HDX-MS), and disulfide bond profiling. Our con-
clusion is that the introduction of a flexible linker does not allow
native-like trimers to be produced unless either one or both of
the I559P and SOS changes are also present. Accordingly, we can-
not independently verify the report that the 92UG037.8 and
CZA97.012 standard uncleaved gp140 proteins and the flexible
linker-containing 92UG037.8 gp140-FL20 variant form predom-
inantly native-like trimers (42). We also describe how affinity pu-
rification strategies, including the use of different bNAb columns,
influence the production of fully native-like trimers, as opposed to
mixtures of native-like and nonnative forms. Finally, we describe
the successful production and some of the properties of fully
native-like SOSIP.664 trimers based on the 92UG037.8 and
CZA97.012 env genes. It is noteworthy that native-like CZA97.012
SOSIP.664-His trimers are almost entirely free of gp120 subunits
that are misfolded as a result of disulfide bond scrambling, which
in contrast are abundant in the uncleaved CZA97.012 gp140 pro-
teins. These two new SOSIP.664 trimers will be evaluated further
as both immunogens and structural substrates.
MATERIALS AND METHODS
Env protein design. The designs of the various Env proteins described in
this report are summarized in Fig. 1. The CZA97.012 and 92UG037.8 env
gene sequences and plasmids expressing the gp140UNC-Fd-His proteins
were obtained from B. Chen (Harvard University) and are the basis of the
uncleaved gp140 proteins described in multiple publications (2, 4, 34, 42,
43). In some reports, the same genes or proteins have sometimes been
referred to as C97ZA012, 97ZA012, UG037, UG37, etc. The gp140UNC-
Fd-His proteins contain the gp120 subunit linked to gp41ECTO via an
uncleaved peptide. The gp41ECTO subunit terminates after residue 683,
which is immediately followed by the Fd domain and then a six-histidine
residue affinity purification tag. The 92UG037.8 gp140-FL20 construct is
based on gp140UNC-Fd-His but contains a 20-residue flexible linker
(FL20) (SGGGG repeated four times) between the C terminus of gp120
and the N terminus of gp41ECTO, exactly as described previously (42). The
I559P change was made to this construct to create gp140-FL20-IP, and
both the I559P change and the substitutions needed to introduce the
intersubunit disulfide bond (A501C plus T605C) were added to make
gp140-FL20-SOSIP (Fig. 1).
The CZA97.012 and 92UG037.8 SOSIP.664-His constructs were made
by cloning the corresponding env genes into the pPPI4 expression vector
and then making the following changes, as described previously (18, 28).
The natural leader sequence was replaced with the tissue plasminogen
activator leader, the A501C, T605C, and I559P substitutions were added,
the REKR cleavage site at residues 508 to 511 was replaced with the RR
RRRR sequence, and gp41ECTO was terminated at residue 664, which was
followed by a single Gly and then the six-histidine affinity tag. In addition,
the 92UG037.8 construct contains an I535M substitution, and the
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CZA97.012 construct contains the L535M and Q567K changes, which
improve trimer formation and expression (unpublished data based on
work in reference 44).
Env protein expression and purification. The various CZA97.012
and 92UG037.8 Env proteins were expressed by transient transfection of
293F cells, essentially as previously described (28). The gp140UNC-Fd-His,
gp140-FL20, gp140-FL20-IP, and gp140-FL20-SOSIP proteins were iso-
lated from culture supernatants via their His tags, using nickel-nitrilotri-
acetic acid (Ni-NTA) affinity columns and elution with 250 mM imida-
zole, essentially as recommended by the manufacturer (Life Technologies
Inc.) (2, 42). The SOSIP.664-His proteins were purified from culture su-
pernatants using affinity columns containing either Galanthus nivalis ag-
glutinin (GNA)-lectin or one of the 2G12, PGT145, or PGT151 bNAbs,
and then similarly fractionated by size exclusion chromatography (SEC)
(18, 45). The affinity columns were made using a CNBr-activated Sephar-
ose 4B resin (GE Healthcare) as previously described (18). In each case,
the culture supernatant was passed through the column at a constant rate
of 1 ml/min, the beads were washed with buffer (20 mM Tris-HCl, 500
mM NaCl [pH 8]), and the Env proteins were eluted with 3 M MgCl2 (pH
7.2). The eluted proteins were immediately buffer exchanged into 10 mM
Tris-HCl–75 mM NaCl (pH 8) and concentrated using a 100-kDa-cutoff
Vivaspin column (GE Healthcare). SEC was used to size fractionate the
affinity-purified proteins on a Superdex 200 26/60 column with the same
buffer. The isolated trimer fractions were pooled, concentrated, and
stored at 80°C.
SDS-PAGE and blue native PAGE. Purified Env proteins were ana-
lyzed using 4 to 12% Bis-Tris NuPAGE SDS-PAGE or blue native
PAGE (BN-PAGE) gel systems (Invitrogen), followed by Coomassie
blue staining. To analyze cleavage, the proteins were incubated for 10
min at room temperature with 0.1 mM dithiothreitol (DTT) before
FIG 1 Schematic representations of Env proteins. Linear representations of the 92UG037.8- and CZA97.012-based Env proteins used in these studies are shown,
with variable and conserved domains (conserved domain 1 [C1] to C5 and variable domain 1 [V1] to V5) and the positions and classifications of glycan moieties
indicated. The following elements are on all the constructs: heptad repeat 1 (HR1), heptad repeat 2 (HR2), and membrane-proximal external region (M). The
full-length gp160 protein, not made in this study, contains transmembrane (TM) and cytoplasmic domains that are absent from the soluble proteins. The
SOSIP.664-His constructs contain the intersubunit (gp120-gp41ECTO) disulfide bond (A501C plus T605C), the I559P substitution, and R6 cleavage-enhancing
change, all shown in red. Compared to the 92UG037.8 virus sequence, the corresponding SOSIP.664-His trimer also contains an amino acid substitution, I535M,
shown in blue. Similarly, the additional substitutions in the CZA97.012 SOSIP.664-His trimer, also shown in blue, are L535M and Q567K. These changes are not
present in the corresponding uncleaved gp140UNC-Fd-His proteins. The Foldon (Fd) domains present in the uncleaved gp140s are black, and the His tags are
yellow. The 20-residue flexible linkers (FL20s) added to the 92UG037.8 gp140-FL20, gp140-FL20-IP, and gp140-FL20-SOSIP constructs are red, as are the IP and
SOSIP changes present in the latter two constructs.
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they were loaded onto the SDS-polyacrylamide gels. BN-polyacryl-
amide gels were used to analyze the trimer fractions derived from SEC
column runs.
Protease digestion. Purified Env proteins (4 g) were incubated with
a range of concentrations of trypsin, chymotrypsin or proteinase K (all
from Sigma) for 1 h at 37°C before analysis by reducing SDS-PAGE (with
DTT) as described above.
Antibodies. Monoclonal antibodies (MAbs) were obtained as gifts or
purchased from the following sources (shown in parentheses): VRC01
and F105 (John Mascola); PG9, PG16, PGT122, PGT128, PGT135,
PGT145, PGT151, b6, b12, and F240 (International AIDS Vaccine Initia-
tive); 2G12 (Polymun Scientific); 3BNC60 and 8ANC195 (Michel Nus-
senzweig); 39F, 17b, 19b, and 14e (James Robinson); 35O22 (Mark Con-
nors); and CH103 (Barton Haynes).
Surface plasmon resonance. Surface plasmon resonance (SPR) assays
were carried out as described previously (26). Briefly, purified His-tagged
Env proteins were captured onto CM5 chips by an anti-His MAb (GE
Healthcare), which was covalently immobilized in an amount yielding
15,000 response units (RU). Since Env proteins with and without the
Foldon moiety differ by 5% in total mass, we sought to immobilize all
Env proteins in amounts yielding similar signals (mean, 527 RU; 95%
confidence interval [95% CI] of mean, 525 to 530 RU). The CD4-IgG2
protein and all the MAbs except 2G12 were then injected at a concentra-
tion of 500 nM. The 2G12 MAb was injected at 62 nM, because we found
that when it was added at 500 nM, it bound Env proteins at levels that are
greater than the expected stoichiometry of one IgG per gp120. This out-
come may reflect a second, lower-affinity interaction between 2G12 and
Env (46, 47). The flow rate was 50 l/min throughout the MAb associa-
tion and dissociation phases. After each cycle of MAb association and
dissociation, the anti-His surface was regenerated by injecting a single
pulse of 10 mM glycine (pH 1.5) for 60 s at a flow rate of 30 l/min.
Enzyme-linked immunoabsorption assay (ELISA). Briefly, purified
His-tagged Env proteins were captured onto preblocked Ni-NTA 96-well
plates (Qiagen) via their tags by incubation for 2 h at 0.5 g/ml in Tris-
buffered saline (TBS) containing 5% fetal bovine serum (FBS). The test
MAbs or related reagents were then added for 1 h in the same buffer.
Bound MAbs were detected using an appropriate horseradish peroxidase
(HRP)-conjugated secondary antibody and the 3,3=,5,5=-tetramethylben-
zidine (TMB) substrate system with an optical density endpoint at 450
nm (Bio-Rad). The 50% binding values (50% effective concentrations
[EC50s]) for MAb binding were calculated by plotting the nonlinear re-
gression curves using Prism software, version 5.0.
Neutralization assay. The neutralization sensitivity of Env-pseu-
dotyped viruses was determined using the Tzm-bl cell assay as described
previously (18, 28). The test viruses are based on the full-length env genes.
All assays were performed in duplicate. Virus infectivity in the absence of
a test MAb was defined as 100%. The MAb concentrations reducing in-
fectivity by 50% (IC50s) were calculated from nonlinear regression fits of
a sigmoid function to the normalized inhibition data by the use of Prism
software, version 5.0.
Correlations between the neutralization assay IC50s and the ELISA
EC50s were investigated using the nonparametric Spearman’s rank corre-
lation test and the same software program.
Differential scanning calorimetry (DSC). The thermal denaturation
of purified Env proteins, previously dialyzed into phosphate-buffered sa-
line (PBS) and added to the test cell at a concentration of 100 to 300
g/ml, was probed using a MicroCal VP-Capillary DSC calorimeter
(Malvern Instruments) as described previously (18). The scan rate for the
temperature increase was 90°C/h. Buffer correction, normalization, and
baseline subtraction procedures were applied before the data were ana-
lyzed using Origin 7.0 software. The resulting data were fitted using a
non-two-state model, as the asymmetry of some of the thermal denatur-
ation peaks suggested that unfolding intermediates were present.
Glycan profiling of Env proteins. N-linked glycosylation profiles of
purified Env proteins were determined by hydrophilic interaction liquid
chromatography-ultraperformance liquid chromatography (HILIC-UPLC)
as previously described (39). Briefly, purified Env proteins (10 g) were frac-
tionated by SDS-PAGE under reducing or nonreducing conditions. The gels
were stained with Coomassie blue. Bands corresponding to the gp140, gp120,
or gp41ECTO species were excised from the gels, which were washed with
acetonitrile and then washed with water; this procedure was repeated five
times. N-linked glycans were then released by addition of protein N-glycosi-
dase F (PNGase F) at 5,000 U/ml and incubation at 37°C for 16 h, according
to the manufacturer’s instructions (New England BioLabs [NEB]). Released
glycans were eluted from the gel bands by extensive washing with water, dried
using a SpeedVac concentrator, labeled with 2-aminobenzoic acid (2-AA),
and then purified as previously described (39). Fluorescently labeled glycans
were resolved by HILIC-UPLC using a Acquity BEH amide column (2.1 mm
by 10 mm) as described previously (39). Data processing was performed us-
ing Empower 3 software. The percentage abundance of oligomannose-type
glycans was calculated by integration of the relevant peak areas before and
after endoglycosidase H digestion, following normalization.
Hydrogen/deuterium exchange mass spectrometry (HDX-MS).
The 92UG037.8 and CZA97.012 SOSIP.664-His trimers were purified
by bNAb PGT145 and PGT151 columns, respectively, whereas the
gp140UNC-Fd-His versions were purified by Ni-NTA columns. For all
four proteins, SEC was carried out as described above. After SEC purifi-
cation, the proteins were concentrated to 0.5 mg/ml using Vivaspin
filters (100-kDa molecular-weight cutoff [MWCO]; GE Healthcare). The
HDX methodology, including peptide identification, was performed as
described previously (48). Deuterium exchange was initiated by 10-fold
dilution into deuterated PBS buffer at 23°C. Samples were quenched after
3 s, 1 min, 30 min, and 20 h by mixing 1:1 with ice-cold acidification buffer
(0.2% formic acid, 200 mM Tris 2-carboxyethyl-phosphine [final pH
2.5]). Samples were immediately frozen in liquid nitrogen and stored at
80°C. An internal PPPI peptide at a concentration of 0.5 g/ml was
included to ensure that deuterium labeling conditions were consistent for
each sample (49). Fully deuterated control samples were prepared by de-
naturing gp140 samples in 4 M guanidinium hydrochloride (Gnd-
HCl)–20 mM DTT at 85°C for 30 min, followed by a 10-fold dilution into
deuterated PBS and incubation at 60°C for 2 h.
Liquid chromatography coupled to mass spectrometry (LC/MS) was
performed by manually loading samples onto a Waters HDX manager
coupled with a Waters Synapt G2Si mass spectrometer. The samples were
passed through a pepsin column (2.1 by 50 mm) (kept at 0.5°C) at a flow
rate of 150 l/min and subsequently loaded onto a Waters Vanguard C18
guard column (2.1 by 5 mm). A gradient of 5 to 50% solvent B (solvent A
consisted of 0.1% formic acid, 0.04% trifluoroacetic acid, and 2% aceto-
nitrile; solvent B consisted of 99.9% acetonitrile and 0.1% formic acid)
was used to resolve the peptides over a BEH C18 column (1 by 100 mm)
(Waters) at 40 l/min, which was also kept at 0.5°C. After each injection,
the pepsin column (50), the trap, and the analytical columns (51) were
extensively washed to minimize sample carryover. The resulting data were
analyzed using HX-Express v2 (52). The percent exchange is reported for
each peptide relative to zero and fully deuterated standards. Error bars
reflect the standard deviations between duplicate measurements. The
data from the 92UG037.8 monomeric gp120 protein and the BG505
SOSIP.664 trimer were published previously (41, 48).
Analysis of disulfide bond formation in Env proteins. Disulfide bond
patterns in CZA97012 gp140 glycoproteins were determined by liquid
chromatography coupled to tandem mass spectrometry (LC/MS/MS)
analysis of tryptic digestion products of alkylated and deglycosylated
gp140 samples, as described previously (53, 54). In brief, 50 g of pro-
tein was alkylated with 4-vinylpyridine to cap free cysteine residues prior
to deglycosylation. Samples were subsequently deglycosylated with
PNGase F at 37°C for a week. Fully deglycosylated, alkylated samples were
digested overnight with trypsin and were subsequently analyzed using a
linear ion trap (LTQ) Orbitrap Velos Pro (Thermo Scientific, San Jose,
CA) mass spectrometer coupled to an Acquity ultraperformance liquid
chromatography (UPLC) system (Waters, Milford, MA). Chromatogra-
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phy was performed using mobile phases consisting of solvent A (99.9%
deionized H2O plus 0.1% formic acid) and solvent B (99.9% CH3CN plus
0.1% formic acid) and a 3% to 40% solvent B gradient in 50 min at 5
l/min through a C18 PepMap 300 column (300-m inner diameter [i.d.]
by 15 cm and 300-Å pore size; Thermo Scientific Dionex, Sunnyvale, CA).
Mass spectrometric (MS) analysis was performed in a data-dependent
acquisition mode consisting of one full MS scan followed by three MS/MS
events of the top three most intense ions. Each ion was sequentially and
dynamically selected for collision-induced dissociation (CID), electron
transfer dissociation (ETD), and CID of the charge-reduced precursor in
the previous ETD event in the LTQ mass spectrometer. The presence of
each disulfide-bonded peptide was determined using high-resolution MS,
with 10 ppm as the maximum mass error, and confirmed by manual
assignment of the corresponding MS/MS data, as described previously
(54, 55).
Negative-stain electron microscopy. Env proteins were prepared for
negative-stain electron microscopy (EM) analysis as previously described
(18, 28). Briefly, a 3-l aliquot containing 0.01 to 0.05 mg/ml of Env
protein (as determined by UV spectroscopy at 280 nm using a theoretical
extinction coefficient based on the peptide sequence alone) was applied
for 5 s onto a carbon-coated 400-mesh Cu grid that had been glow dis-
charged at 20 mA for 30 s and then negatively stained with 2% (wt/vol)
uranyl formate for 60 s. Grids were screened to assess stain quality and
particle distribution. The sample concentration was adjusted, and the
grids were remade until the particle overlap on the grid surface had been
minimized. Data were collected either on an FEI Tecnai T12 electron
microscope operating at 120 keV, with an electron dose of 25 e/Å2 and
a magnification of 52,000 that resulted in a pixel size of 2.05 Å on the
specimen plane, or on an FEI Talos electron microscope operating at 200
keV, with an electron dose of 25 e/Å2 and a magnification of 73,000
that resulted in a pixel size of 1.98 Å on the specimen plane. Images were
acquired with a Tietz TemCam-F416 CMOS camera (FEI Tecnai T12) or
a FEI Ceta 16M camera (FEI Talos) using a nominal defocus range of
1,000 to 1,500 nm.
Data processing methods were adapted from those used previously
(28). The resulting two-dimensional (2D) class averages were visually
inspected, and discernible aggregates, dimers, and monomers (based on
relative mass/size) were removed from an additional round of 2D classi-
fication. The updated classes were segregated into one of three structural
groups labeled closed, open, or nonnative as described previously (28).
The amount of native-like particles was defined as the sum of closed and
open particles.
RESULTS
Design, expression, and biochemical properties of gp140 pro-
teins. The various gp140 proteins shown in Fig. 1 were based on
the 92UG037.8 (clade A) and CZA97.012 (clade C) env gene se-
quences. The design of the standard uncleaved gp140 proteins,
here designated gp140UNC-Fd-His, is identical to the designs of
the gp140 proteins described in multiple publications (2, 42, 43).
The natural REKR cleavage site between gp120 and gp41ECTO is
present in both these gp140 constructs but is used to a negligible
extent (see below). The Foldon domain and a His tag are present at
the gp41ECTO C termini, again as described previously (2, 42, 43).
Variants of these proteins containing additional modifications are
described below. The SOSIP.664-His versions of the 92UG037.8
and CZA97.012 proteins were made by introducing an optimized
cleavage site (RRRRRR), the SOS disulfide bond to link the gp120
and gp41ECTO subunits, and the I559P substitution in gp41ECTO,
all of which have been described elsewhere (18). In addition, the
92UG037.8 and CZA97.012 SOSIP.664-His gp140s contain one
substitution and two other substitutions in gp41ECTO, I535M and
L535M plus Q567K, respectively, that modestly improve trimer
formation (44). The SOSIP trimers also include a C-terminal His
tag immediately after residue 664 to allow a comparison with the
uncleaved gp140UNC-Fd-His proteins in antigenicity assays such
as SPR assay and ELISA (Fig. 1).
The above four Env proteins were produced in 293F cells by
transient transfection using 293Fectin. For expression of the
SOSIP.664-His proteins, furin was cotransfected to facilitate
gp140 cleavage (18). However, furin was not cotransfected with
the gp140UNC-Fd-His proteins to ensure comparability with ear-
lier reports on the properties of these proteins (2, 42, 43). The
92UG037.8 and CZA97.012 gp140UNC-Fd-His gp140s were puri-
fied via their His tags using Ni-NTA columns as described previ-
ously, followed by SEC (Ni-NTA/SEC) to isolate the trimer frac-
tion (2, 42). We used this procedure to maximize comparability
between our data and what has been reported for the same pro-
teins (2, 4, 5, 42). We conducted pilot experiments to assess how
best to purify the newly generated 92UG037.8 and CZA97.012
SOSIP.664-His trimers, in a form that was as fully native-like as
possible. Initial antigenicity studies on unpurified transfection su-
pernatants suggested that a 2G12 bNAb column and a GNA-lectin
column, again followed by SEC, would be suitable for making
initial preparations of 92UG037.8 and CZA97.012 SOSIP.664-His
trimers, respectively. The resulting purified trimers were studied
by negative-stain EM and found to contain mixtures of native-like
and nonnative trimers in approximately equal amounts (Fig. 2A).
FIG 2 Negative-stain EM reference-free 2D class averages of 92UG037.8 and
CZA97.012 SOSIP.664-His and gp140UNC-Fd-His proteins purified by differ-
ent methods. (A) 92UG037.8 SOSIP.664-His trimers purified by 2G12/SEC
and CZA97.012 SOSIP.664-His trimers purified by GNA-lectin/SEC; (B)
92UG037.8 SOSIP.664-His trimers purified by PGT145/SEC and CZA97.012
SOSIP.664-His trimers purified by PGT151/SEC; (C) 92UG037.8 and
CZA97.012 gp140UNC-Fd-His proteins purified by Ni-NTA/SEC. The per-
centage of native-like trimers is listed below each set of class averages. Any
discernible aggregates, dimers, and monomers (based on relative mass/size)
are not included in the class averages or the calculations of the percentage of
native-like trimers.
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However, pilot-scale antigenicity assessments showed that the
92UG037.8 and CZA97.012 SOSIP.664-His trimers reacted well
with the trimer-specific (i.e., quaternary structure-dependent)
bNAbs PGT145 and PGT151, respectively (data not shown). On
the basis of our earlier use of PGT145 columns, we judged that we
could purify fully native-like SOSIP.664-His trimers by positive
selection followed by SEC (28, 39). The Ni-NTA column is not
appropriate for purifying either SOSIP.664-His trimer, because as
noted previously, this method is not conformationally selective
and yields mixtures of native-like and nonnative trimers (39).
When EM was used to visualize the PGT145/SEC-purified
92UG037.8 SOSIP.664-His trimers and PGT151/SEC-purified
CZA97.012 SOSIP.664-His trimers, essentially all were found to
be native-like, with 90% in the fully closed conformation
(Fig. 2B). The yield of trimers purified by positive selection was
reduced by 2.5-fold compared to the lectin/SEC and 2G12/SEC
methods, reflecting the elimination of the nonnative trimer com-
ponents. Although SEC is not strictly necessary to purify trimers
that have already been isolated via the trimer-specific bNAb col-
umns, we continued to routinely use this secondary technique to
allow comparability with the uncleaved 92UG037.8 and
CZA97.012 gp140s, for which the SEC stage was essential.
SEC profiles of the PGT145- or PGT151-purified SOSIP.664-
His gp140 preparations showed sharp, trimer-containing peaks.
The very few protein aggregates (5%) present were well sepa-
rated from the trimer fractions (Fig. 3A). The deletion of the
membrane-proximal external region (MPER) and the occlusion
of other hydrophobic areas of gp41ECTO by the overlying gp120
FIG 3 SEC profiles of SOSIP.664-His and gp140UNC-Fd-His proteins. (A) PGT145-purified 92UG037.8 and PGT151-purified CZA97.012 SOSIP.664-His
proteins; (B) Ni-NTA-purified 92UG037.8 and CZA97.012 gp140UNC-Fd-His proteins. In panel B, the arrows show when collection of the trimer fractions was
initiated. (C) The trimer fractions shown in panel B were pooled and reanalyzed by SEC (ReSEC). In each panel, the x axis shows the fractions collected over time
and the y axis shows absorbance at 280 nm. In each panel, the inset shows a BN-polyacrylamide gel with the most prominent bands indicated.
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subunits accounts for why SOSIP.664 proteins aggregate only
minimally (1, 8, 45, 56). In contrast, the SEC profiles of the Ni-
NTA-purified gp140UNC-Fd-His proteins revealed a quantita-
tively dominant single peak that contained high-molecular-
weight (MW) protein aggregates, followed by trimers, with a small
amount (1 to 3% of the total) of later-eluting gp140 monomers
also present (Fig. 3B, graphs). The overlap with the aggregated
material complicates purification of uncleaved trimers, which ac-
cordingly often contain significant amounts of aggregates (2, 4, 42,
43). Some of these forms represent disulfide cross-linked gp140
oligomers (see below), while others probably arise via nonco-
valent associations involving the membrane-proximal external
region (MPER) and other hydrophobic areas of gp41ECTO.
Nonetheless, by adopting a conservative fraction collection
strategy that favored purity over yield (see arrows in Fig. 3B),
we were able to isolate gp140UNC-Fd-His proteins that mi-
grated as a single peak when they were reanalyzed by SEC (Fig.
3C, graphs) and ran as a single band on a BN-polyacrylamide
gel (Fig. 3C, insets). Negative-stain EM images of these pro-
teins were taken (Fig. 2C) and are described below.
Reducing versus nonreducing SDS-polyacrylamide gels were
then used to further study the gp140 proteins that were purified by
affinity columns (PGT145 or PGT151) and then SEC (Fig. 4A).
The SOSIP.664-His trimers ran as single bands and were both fully
cleaved between gp120 and gp41ECTO, as indicated by the conver-
sion of the gp140 band into gp120 in the presence of DTT. In
contrast, the two gp140UNC-Fd-His proteins were completely un-
cleaved (i.e., no conversion of gp140 to gp120 when DTT was
present). Higher-MW aggregates were clearly visible in the un-
cleaved gp140 preparations when the gels were run under nonre-
ducing conditions, and their sensitivity to DTT implies that they
are the products of gp140 cross-linking via intermolecular disul-
fide bonds (Fig. 4B). Such disulfide bond-linked aggregates are
routinely seen in uncleaved gp140 preparations (32, 36, 57). How
they arise is discussed further below.
Protease sensitivity of SOSIP.664-His trimers and gp140UNC-
Fd-His proteins. The protease sensitivity of the purified gp140
proteins was studied by incubating them with various concentra-
tions of trypsin, chymotrypsin, or proteinase K for 1 h at 37°C
followed by reducing SDS-PAGE (Fig. 5). The two SOSIP.664-His
trimers were unaffected by trypsin and chymotrypsin under these
conditions, but the 92UG037.8 trimers were partly and nearly
completely degraded at proteinase K concentrations of 0.1 and 1
g/ml, respectively, and CZA97.012 trimers were completely de-
graded at a proteinase K concentration of 1 g/ml. In contrast,
both of the gp140UNC-Fd-His proteins were almost completely
digested by each of the three proteases at 1 g/ml and were detect-
ably damaged by 10-fold-lower concentrations. Overall, the
SOSIP.664-His trimers are more than 10-fold more resistant to
proteases, which is consistent with earlier reports (19, 30).
Negative-stain EM imaging of optimally purified SOSIP.664-
His trimers and gp140UNC-Fd-His proteins. As noted above, we
first obtained EM images of the 92UG037.8 and CZA97.012
SOSIP.664-His trimers to guide the design of the optimal purifi-
cation strategy for these proteins (Fig. 2A). When the 92UG037.8
and CZA97.012 SOSIP.664-His trimers were purified by PGT145/
SEC and PGT151/SEC, respectively, and analyzed by EM, these
trimers are indistinguishable from their well-characterized 2G12/
SEC-purified BG505 SOSIP.664 counterparts, in that all three
trimer populations are almost completely native-like and domi-
nated by fully symmetric, trilobed structures (Fig. 2B). Moreover,
these trimers are predominantly in the fully closed conformation
(90% for both 92UG037.8 and CZA97.012), again mirroring the
appearance of the BG505 trimers (100% closed). The re-
maining trimer structures are still native-like but partially
open, akin to what we have described as a major subpopulation
FIG 4 SDS-PAGE analysis of SOSIP.664-His and gp140UNC-Fd-His proteins. (A and B) Reducing gels (i.e., with DTT [ DTT]) versus nonreducing gels of
PGT145/SEC-purified 92UG037.8 and PGT151/SEC-purified CZA97.012 SOSIP.664-His trimers (A) and Ni-NTA-purified 92UG037.8 and CZA97.012
gp140UNC-Fd-His proteins (B). The positions of gp120 and gp140 bands are indicated by the black lines or black arrow to the right of the gels. The positions of
molecular mass markers (in kilodaltons) are indicated to the left of the gels.
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in B41 SOSIP.664 trimer preparations (28). Versions of the two
new SOSIP.664 trimers that lack the His tag are indistinguish-
able from their tagged counterparts (data not shown).
In marked contrast, native-like trimer structures were very
rarely seen (5% frequency) in each of the two Ni-NTA/SEC-
purified gp140UNC-Fd-His preparations (Fig. 2C). Instead, the
predominant images depict splayed-out structures that represent
decayed or never-formed trimers held together by the uncleaved
peptide linking gp120 to gp41ECTO. The images are highly similar
to what has been found with several other uncleaved gp140s of the
standard (i.e., nonlinker) design, based on various genotypes and
containing or lacking a Foldon domain (7, 16, 19, 30, 39).
Antigenic structures of SOSIP.664-His and gp140UNC-Fd-
His proteins assessed by SPR. We used SPR to compare the anti-
genicity of the Ni-NTA/SEC-purified 92UG037.8 and CZA97.012
gp140UNC-Fd-His proteins with the corresponding fully native-
like SOSIP.664-His trimers (i.e., PGT145/SEC purified for
92UG037.8, PGT151/SEC purified for CZA97.012) (Fig. 6A and
FIG 5 Protease sensitivity of SOSIP.664-His trimers and gp140UNC-Fd-His proteins. (A and B) 92UG037.8 (A) and CZA97.012 (B) proteins were incubated with
the indicated concentrations (in nanograms per milliliter) of trypsin, chymotrypsin, or proteinase K for 1 h at 37°C and analyzed by reducing SDS-PAGE. The
92UG037.8 and CZA97.012 SOSIP.664-His trimers were purified by the PGT145/SEC and PGT151/SEC methods, respectively, and the two gp140UNC-Fd-His
proteins were purified via Ni-NTA/SEC. In panels A and B, the 0-concentration lanes of the trypsin and chymotrypsin gels are duplicate depictions of the same
control samples, as they are common to both of the protease titration experiments that were performed simultaneously and analyzed on the same gel.
FIG 6 SPR analyses of SOSIP.664-His trimers and gp140UNC-Fd-His proteins. Association and dissociation profiles for the indicated MAbs are shown.
CD4-IgG2 and all MAbs other than 2G12 at 500 nM flowed over His tag-immobilized Env proteins that were present on the chips in equivalent amounts (5%
standard deviation [SD]). The 2G12 MAb was injected at 62 nM (see Materials and Methods). (A) 92UG037.8 proteins; (B) CZA97.012 proteins. Note that the
y-axis scales differ among the plots. The Env proteins were purified as described in the legend to Fig. 5.
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B). In this SPR method, the Env proteins are first captured onto
CM5 chips via their His tags, which are recognized by a covalently
bound anti-His MAb. Anti-Env MAbs are then allowed to flow
over the captured Env proteins, and the MAb-Env association and
dissociation phases are recorded (26). In all experiments, equiva-
lent amounts of different Env proteins were confirmed to be pres-
ent on the SPR chips, allowing their reactivity with test MAbs to be
compared directly. In contrast, the more commonly used SPR
method in which the Env protein flows in a solution over chip-
immobilized MAbs does not allow such comparisons, and in ad-
dition, this method often detects the MAb binding of only a small
subset of the input proteins (2, 5, 26).
Several bNAbs and non-NAbs against the CD4 binding site
(CD4bs), and the CD4-IgG2 protein, were used to probe the ac-
cessibility of this region of the 92UG037.8 Env proteins (Fig. 6A).
The VRC01 and 3BNC60 bNAbs and the CD4-IgG2 protein each
bound to both Env proteins, but the maximum signals were 1.5- to
2-fold greater for SOSIP.664-His than for gp140UNC-Fd-His. In
contrast, the b6 and F105 non-NAbs to CD4bs-associated
epitopes reacted only minimally with the SOSIP.664-His trimer,
but they reacted strongly with the gp140UNC-Fd-His protein.
CH103, a CD4bs MAb, which had some breadth of reactivity over-
all but was only weakly neutralizing and nonneutralizing for the
92UG037.8 and CZA97.012 Env-pseudotyped viruses (IC50s, 12.3
and 30 g/ml, respectively; Table 1), behaved similarly to b6 and
F105 when tested against the two 92UG037.8 Env proteins (and
also the two CZA97.012 proteins) (Fig. 6A and B). The pattern of
reactivity with the CD4bs suggests that the quaternary structural
constraints on the accessibility of non-bNAb epitopes are much
greater within the SOSIP.664-His trimers, which instead present
the bNAb epitopes better than the gp140UNC-Fd proteins do. The
non-NAb 17b to a CD4-induced (CD4i) epitope bound weakly to
the gp140UNC-Fd-His protein in the absence of soluble CD4
(sCD4), but its epitope was induced by prior CD4-IgG2 binding
(RU values of 29 	 0.50 versus 110 	 1.7 [mean 	 standard error
of the mean{SEM}], with and without CD4-IgG2, respectively).





ELISA binding EC50 (ng/ml)
Neutralization IC50
(ng/ml)





CD4bs CD4-IgG2 1,900 5,000 65 3,900 5,000 200
VRC01 230 350 50 900 6,500 300
3BNC60 40 1,100 180 400 6,000 5,000
CH103 12,300 10,000 550 30,000 10,000 300
b12 30,000 10,000 5,000 30,000 10,000 5,000
b6 30,000 10,000 400 30,000 10,000 110
F105 30,000 10,000 450 30,000 10,000 5,000
V1/V2-glycan PG9 160 3,600 10,000 30,000 10,000 10,000
PG16 30 550 10,000 30,000 10,000 10,000
PGT145 3,150 1,370 10,000 4,160 10,000 10,000
V3-glycan PGT122 1,200 4,000 550 40 115 800
PGT128 50 218 25 80 100 500
OD-glycan 2G12 30,000 2,910 5,000 30,000 10,000 10,000
PGT135 30,000 10,000 9,000 30,000 10,000 10,000
gp120-gp41 interface PGT151 30,000 10,000 10,000 170 100 10,000
35022 30,000c 55 10,000 30,000 1,000 10,000
8ANC195 6,700 5,000 10,000 30,000 10,000 10,000
MPER 2F5 3,024d NA 10,000 30,000d NA 10,000
4E10 8,840d NA 10,000 4,700d NA 10,000
V3 14e 30,000 10,000 150 30,000 10,000 300
19b 30,000 10,000 600 30,000 10,000 10,000
39F 30,000 10,000 520 30,000 10,000 1,000
CD4i 17b 30,000 10,000 9,000 30,000 10,000 1,600
Cluster I (gp41) F240 30,000 10,000 25 30,000 10,000 20
a The test MAbs are grouped by epitope cluster.
b The values shown in the table are 50% neutralization titers (IC50 [in nanograms/milliliter]) derived from Env-pseudotyped virus-based assays in Tzm-bl cells and midpoint
binding titers (EC50 [in nanograms/milliliter]) from His tag ELISAs using the SOSIP.664-His and gp140UNC-Fd-His Env proteins. The  symbol in front of values indicates that
endpoints were not achieved at MAb concentrations of 30,000 ng/ml in the neutralization assay or 10,000 ng/ml in the ELISA. NA, not applicable (SOSIP.664 trimers do not express
epitopes for bNAbs against the MPER).
c For bNAb 35O22 versus the 92UG037.8 virus, an IC50 could not be determined precisely because the extent of neutralization reached a plateau value at 50% (see the text).
d Values for neutralization by MAbs 2F5 and 4E10 were derived from reference 87.
Design and Purification of Native-Like HIV-1 Trimers
December 2015 Volume 89 Number 23 jvi.asm.org 12197Journal of Virology
 on D
ecem









However, the extent to which CD4-IgG2 induced the 17b epitope
was much greater on the SOSIP.664-His trimer, and the epitope
was not accessible before CD4-IgG2 addition (RU values of 8.0 	
2 versus 370 	 7.1 with and without CD4-IgG2, respectively). The
V3-targeting non-NAbs 14e and 19b and the gp41 cluster I non-
NAb F240 all bound strongly to the gp140UNC-Fd-His protein, but
negligibly to the SOSIP.664-His trimer. The PGT122 bNAb
against a glycan-dependent V3 epitope reacted better with the
gp140UNC-Fd-His protein, but the converse applied to the
PGT128 bNAb against a similar V3-glycan epitope. The 2G12
bNAb reacted more strongly with the SOSIP.664-His trimer by
approximately twofold, again judged by the maximum level of
binding. The influence of appropriate trimerization on epitope
exposure was dramatically illustrated by the antigenicity pro-
files for the trimer-specific or trimer-influenced bNAbs PG9,
PG16, PGT145, PGT151, and 35O22, which bound only, or to
vastly greater extents, to the SOSIP.664-His trimers. It is note-
worthy that a very rapid off-rate was observed for PGT151 (see
below). Thus, the 92UG037.8 SOSIP.664-His proteins have all
the hallmarks of native-like trimers, while their uncleaved
gp140UNC-Fd-His counterparts have none of the hallmarks
(Fig. 6A). The SPR antigenicity profiles are therefore entirely
concordant with the EM images of the same 92UG037.8 Env
proteins (Fig. 2B and C).
A very similar SPR data set was obtained using the two
CZA97.012 Env proteins, leading to the same conclusion that the
SOSIP.664-His trimers are native-like structures that display qua-
ternary epitopes (i.e., PG9, PG16, PGT145, 35O22, PGT151). The
PGT151 bNAb against one such epitope at the gp120-gp41 inter-
face bound with high affinity, but bNAbs PG9, PG16, and PGT145
to trimer apex epitopes had rapid dissociation rates (see below). In
contrast, the gp140UNC-Fd-His proteins lack these critical proper-
ties (Fig. 6B). Again, the antigenicity profiles are consistent with
the respective EM images (Fig. 2B and C). Unlike 92UG037.8,
CZA97.012 gp120 lacks a glycan at residue 295. This glycan site is
generally considered to be one of the principal components of the
2G12 epitope (58–63). Nonetheless, we observed that 2G12 could
still bind efficiently to the CZA97.012 Env proteins in the SPR assay
(Fig. 6B). We also found that, unexpectedly, the 2G12 affinity column
could be used to purify the CZA97.012 SOSIP.664-His proteins, an
observation similar to ones made with other trimers based on differ-
ent clade C env genes (64). The explanation may be rooted in promis-
cuous glycan recognition, where the lack of a glycan from certain
bNAb epitopes, including 2G12, can be compensated for by the pres-
ence of another glycan (46, 47). Here, it is notable that any secondary,
lower-affinity glycan-binding site for 2G12 on SOSIP.664 trimers
may be absent from the gp140UNC-Fd-His proteins, which have non-
native glycan profiles (see below).
In contrast to the results with the 92UG037.8 proteins, the
PGT122 bNAb was more reactive with its V3-glycan epitope on
the CZA97.012 SOSIP.664-His trimer than on the gp140UNC-Fd-
His gp140 (Fig. 6B). However, as with the 92UG037.8 proteins,
PGT128 bound better to its V3-glycan epitope on the CZA97.012
SOSIP.664-His trimer, compared to the corresponding uncleaved
gp140 (Fig. 6B). The lower reactivity of PGT122 with the
92UG037.8 SOSIP.664-His trimers than the corresponding
gp140UNC-Fd-His proteins (also seen in ELISA; Table 1) may re-
late to genotype-dependent glycosylation differences. In general,
uncleaved gp140s have a higher content of processed glycans than
native-like trimers (see below), and the PGT122 epitope, but not
the PGT128 epitope, includes this type of glycan in at least some
sequence contexts (65) The induction of the 17b epitope by CD4-
IgG2 was, again, much greater for the SOSIP.664-His trimer (RU
values of 9.5 	 1.5 versus 280 	 5.5 with and without CD4-IgG2,
respectively) than for the gp140UNC-Fd-His protein (RU values of
34 	 0.50 versus 76 	 1.3). For the CZA97.012 SOSIP.664-His
trimer, the off-rate for PGT145 was rapid, but for PGT151, it was
more moderate, the converse of what was seen with its 92UG037.8
counterpart. The pattern of reactivity of these two exquisitely
trimer-specific bNAbs is consistent with our earlier anecdotal ob-
servations that the PGT145 bNAb column could be used to purify
the 92UG037.8, but not the CZA97.012, SOSIP.664-His trimers
and vice versa for the PGT151 column.
Neutralization of Env-pseudotyped viruses compared to an-
tigenicity of Env proteins in ELISAs. To assess whether there are
antigenic similarities between the 92UG037.8 and CZA97.012 Env
proteins and the native Env spike on the corresponding virus par-
ticles, we first used a panel of bNAbs and non-NAbs as probes
in a Tzm-bl cell-based neutralization assay that used Env-pseu-
dotyped viruses based on the full-length gp120 and gp41 se-
quences. We then tested the same antibodies in a His tag capture
ELISA to measure Env binding and derive EC50s (Fig. 7 and Table
1). We used an ELISA for this purpose because of the greater ease
with which a large panel of MAbs can be tested, compared to the
SPR assay, while being aware of the limitations associated with this
method (18, 28). The test antibodies were again chosen to span a
range of epitopes on the trimer surface. The VRC01 and 3BNC60
bNAbs and the CD4-IgG2 molecule, which all target the CD4bs,
neutralized both Env-pseudotyped viruses, whereas CH103
weakly neutralized only 92UG037.8 and b12 was ineffective
against both viruses (Table 1). As expected, the non-NAbs to
CD4bs (b6 and F105), CD4i (17b), V3 (14e, 19b, and 39F) and
gp41 cluster I (F240) epitopes all failed to neutralize either the
92UG037.8 or CZA97.012 virus (Table 1). The V3-glycan-target-
ing bNAbs PGT122 and PGT128 neutralized both viruses, but the
outer-domain glycan-targeting bNAbs 2G12 and PGT135 neu-
tralized neither. Among the quaternary structure-dependent
bNAbs to epitopes at the trimer apex, PG9, PG16, and PGT145
neutralized the 92UG037.8 virus, but only PGT145 was effective
against the CZA97.012 virus. Of the three bNAbs against quater-
nary epitopes at the gp120-gp41 interface, PGT151, 35O22, and
8ANC195, only 8ANC195 was able to neutralize 92UG037.8 effec-
tively, and only PGT151 was active against CZA97.012.
For each Env protein, the overall set of ELISA EC50s was then
compared with the IC50s for neutralization of the corresponding
Env-pseudotyped viruses, essentially as described previously (18,
28) (Fig. 7A). For the SOSIP.664-His trimers, the resulting Spear-
man’s correlation coefficients, r, were 0.70 (95% confidence inter-
val, 0.39 to 0.87; P  0.0003) and 0.83 (95% confidence interval,
0.63 to 0.93; P  0.0001) for the 92UG037.8 and CZA97.012
SOSIP.664-His trimers, respectively, i.e., the neutralization of the
corresponding Env-pseudotyped viruses correlated well with the
binding to the SOSIP.664-His trimer. In marked contrast, when
similar comparisons were conducted using the ELISA binding
EC50s for the two gp140UNC-Fd-His Env proteins, there were no
correlations with the neutralization sensitivities of the corre-
sponding Env-pseudotyped viruses (r 
 0.06 and 0.16 and P 

0.70 and 0.47 for 92UG037.8 and CZA97.012, respectively [Fig.
7B]). We conclude that the 92UG037.8 and CZA97.012 SO-
SIP.664-His proteins are good antigenic mimics of the func-
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tional Env spikes on the Env-pseudotyped viruses, while the
gp140UNC-Fd-His Env proteins are not.
When we studied the neutralization and ELISA binding data
in more detail, we noted that the 35O22 bNAb bound with
high affinity to its gp120-gp41ECTO interface epitopes on the
92UG037.8 and CZA97.012 SOSIP.664-His trimers but neu-
tralized the corresponding viruses only partially or not at all,
respectively (Table 1 and Fig. 7). Thus, the neutralization
curves for 35O22 and 92UG037.8 reached plateau values at
50%, which implies the existence of a substantial nonneutral-
ized fraction (data not shown). The 35O22 epitope may, in
some sequence contexts, be inherently better presented on a
soluble trimer than on a membrane-associated version, as sug-
gested previously (23, 66). However, it may be relevant that the
structure of the 35022 epitope on the BG505 SOSIP.664 trimer
shows that it probably includes a nonglycosylated form of
gp41ECTO residue N625 (23). Other analyses show that on the
same trimer, the N625 residue is sometimes glycosylated,
sometimes not (48). If virion-associated 92UG037.8 Env pro-
teins are also inconsistently glycosylated at residue N625, that
would account for the partial neutralization of this virus by
35O22 that we report here, and likewise for some other viruses
that are also incompletely neutralized by this antibody (66).
The general subject of why some bNAbs fail to fully neutralize
a subset of viruses has recently been discussed in detail (67).
We also observed that various V3-specific non-NAbs neither
bound to the 92UG037.8 and CZA97.012 SOSIP.664-His trimers
in ELISAs nor neutralized the corresponding viruses. This obser-
vation contrasts with observations of the BG505 and B41
SOSIP.664-D7324 trimers, which do bind the same V3 non-
NAbs in ELISAs (18, 28). In a few cases, we did not detect bNAb
binding in an ELISA despite observing a binding event in the
SPR assay. Examples include PG9, PG16, and PGT145 with
CZA97.012 SOSIP.664-His trimers, PGT151 with 92UG037.8
SOSIP.664-His trimers, and 19b with CZA97.012 gp140UNC-
Fd-His. In all these cases, the SPR profiles show that there is a
high rate of bNAb dissociation from the trimers. This propen-
sity to dissociate may account for why these antibodies did not
bind detectably in ELISAs; this assay involves extensive wash-
ing steps after the antibody-antigen reaction is complete, pro-
viding the opportunity for the antibody to dissociate and be
washed away.
The binding of 2G12 was partially discrepant between ELISA
and SPR assay. This bNAb bound similarly and fairly strongly to
the 92UG037.8 SOSIP.664-His trimers and gp140UNC-Fd-His
proteins in ELISAs, but the maximum signal was twofold higher
against the former than the latter in the SPR assay. For both
CZA97.012 Env proteins, the ELISA binding signal at the highest
input 2G12 concentration was weak and approximately fourfold
lower than against 92UG037.8 Env. Accordingly, EC50s were not
obtainable (Table 1). Differences in the outcomes of the two assays
are probably attributable to the different concentrations of bNAbs
used, which are 10-fold higher in the SPR assay than the highest
concentration added in the ELISA.
As SOSIP.664 trimers are designed to lack most of the MPER,
they do not bind bNAbs against this site. The MPER sequence is
FIG 7 Correlation between antigenicity of SOSIP.664 trimers and neutralization of Env-pseudotyped viruses. The plots for 92UG037.8 and CZA97.012 compare
EC50s for MAb binding derived from His tag capture ELISAs with IC50s derived from TZM-bl cell neutralization assays using the same MAbs and the
corresponding Env-pseudotyped viruses. Data on the MPER-specific bNAbs 2F5 and 4E10 were not included in these analyses, as these epitopes are not present
on SOSIP.664-His trimers. (A) PGT145/SEC- or PGT151/SEC-purified SOSIP.664-His trimers; (B) Ni-NTA/SEC-purified gp140UNC-Fd-His proteins. The MAb
panel tested and the epitopes each MAb recognizes are listed in Table 1. In panel A, data points for multiple non-NAbs are overlapping and circled. Also
highlighted is the anomalous binding of the 35O22 bNAb to the 92UG037.8 SOSIP.664-His trimer despite its limited ability to neutralize the corresponding virus
(see the text). The data points plotted at MAb concentrations of 30,000 ng/ml in the ELISA or 10,000 ng/ml in the neutralization assay represent values that were
endpoints that were not reached in these assays (see Table 1).
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present on the two gp140UNC-Fd-His gp140s, but there are several
reports that bNAbs against MPER epitopes are unable to bind
these proteins (2, 42, 43). We confirmed the lack of binding of
the 2F5 and 4E10 bNAbs to the 92UG037.8 and CZA97.012
gp140UNC-Fd-His proteins in ELISAs (Table 1).
Thermal stability of SOSIP.664-His and gp140UNC-Fd-His
proteins. We used DSC to study the thermal stability of the
PGT145/SEC-purified 92UG037.8 and PGT151/SEC-purified
CZA97.012 SOSIP.664-His trimers and of the Ni-NTA/SEC-pu-
rified 92UG037.8 and CZA97.012 gp140UNC-Fd-His proteins
(Fig. 8). The melting profiles of the 92UG037.8 and CZA97.012
SOSIP.664-His trimers yielded sharp peaks with midpoint tem-
peratures (Tm) of 63.1°C and 68.5°C, respectively. These values
approach or are comparable with those previously reported for
BG505 SOSIP.664 trimers (Tm, 67 to 68°C) (68) and indicate
that the two new trimers are both homogeneous and highly stable.
In contrast, the thermal stability profiles for the gp140UNC-Fd-His
proteins were highly heterogeneous, to the extent that it was dif-
ficult to establish significance with respect to the baseline (Fig. 8,
top panels). The most likely explanation of these melting profiles
is that there are few preexisting interactions between the individ-
ual protomers of the uncleaved gp140s, and hence, little or noth-
ing remains to be denatured as the temperature is increased in the
relevant range. Because of the lack of strong intra- and inter-
protomer interactions, denaturation does not occur over a narrow
temperature range. Instead, heat is released diffusely over an 50°C
range, which contrasts markedly to what was observed with the
SOSIP.664-His trimers (Fig. 8, bottom panels). The absence of a
strong melting signal for the gp140UNC-Fd-His proteins at tempera-
tures of100°C may also reflect how their gp41ECTO-Fd components
have already adopted a conformation similar to the postfusion, six-
helix bundle form, which is highly thermostable (4, 69, 70). This
point is discussed further below.
Conformational flexibility of SOSIP.664-His and gp140UNC-
Fd-His proteins. We used HDX-MS to compare the hydrogen/
deuterium exchange profiles for the optimally purified gp140 pro-
teins of both designs, a technique that measures the relative
solvent accessibility of different regions of proteins (71, 72). Be-
cause of sequence variation between the constructs, only a few
pepsin-generated peptides could be directly compared between all
four 92UG037.8 and CZA97.012 Env proteins (Fig. 9). The com-
parisons show that the exchange profiles for the 92UG037.8 and
CZA97.012 SOSIP.664-His trimers are highly consistent with the
previously described BG505 SOSIP.664 trimer with only minor
differences arising in V2, V3, and the bridging sheet (48). It is
noteworthy that the N- and C-terminal regions of gp120 are
strongly protected, which is consistent with their involvement in
the -sheets that link gp120 to gp41ECTO in the prefusion confor-
FIG 8 Thermal stability of SOSIP.664-His and gp140UNC-Fd-His proteins. DSC profiles and derivative values are shown for PGT145/SEC-purified 92UG037.8
SOSIP.664-His trimers, PGT151/SEC-purified CZA97.012 SOSIP.664-His trimers, Ni-NTA/SEC-purified 92UG037.8 gp140UNC-Fd-His, and CZA97.012
gp140UNC-Fd-His proteins. For the SOSIP.664-His trimers, 40 g was used in each experiment, and for the gp140UNC-Fd-His proteins, 60 g was used. Plots of
the raw data are shown in the top panels, and the baseline and molarity-corrected plots are shown in the bottom panels. Derivative values for the SOSIP.664-His
trimers were determined by modeling a non-two-state curve over the baseline-corrected data. The corresponding values for the gp140UNC-Fd-His proteins could
not be determined because clear peaks were not visible in the raw data. Temperature (in degrees Celsius) is shown on the x axes of the plots; the crossing point
(Cp) (in millicalories or calories per degree) is shown on the y axes of the plots. T1/2, half-life, Tonset, time of onset.
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mation of the trimer (1, 8, 22, 23, 48, 73). Residues 70 to 83 are not
involved in any regular secondary structure but are buried at the
gp120-gp41ECTO interface, which accounts for the slight protec-
tion observed by HDX (Fig. 9). In contrast, very little protection of
the V2, V3, bridging sheet, or gp120-gp41ECTO interface regions
was observed in the two gp140UNC-Fd-His proteins. Hence, these
regions are solvent exposed and not involved in any protective
interactions with other Env domains, an outcome similar to those
seen in earlier studies of monomeric 92UG037.8 gp120 mono-
mers and various other nonnative gp140 proteins (41). The minor
protection seen at the gp120 N terminus of the gp140UNC-Fd-His
proteins was previously observed in nonnative gp140s (41) and
also in gp120 dimers (71).
In the prefusion form of the trimer, residues 593 to 602 of the
gp41ECTO loop region are buried and involved in secondary struc-
ture, whereas in the postfusion conformation, they become un-
structured where they connect the heptad repeat 1 (HR1) and
HR2 helices (48). The strong protection of this region in both the
SOSIP.664-His trimers is consistent with their gp41ECTO compo-
nents being in the native prefusion conformation (Fig. 9). In
marked contrast, the lack of protection of the same region in the
two gp140UNC-Fd-His gp140s is consistent with the earlier con-
clusion that the gp41ECTO subunits adopt a conformation resem-
bling the postfusion form; i.e., similar, but perhaps not identical,
to the six-helix bundle configuration (41).
Glycan compositions of SOSIP.664-His and gp140UNC-Fd-
His proteins. The glycan compositions of native-like SOSIP.664
trimers and uncleaved gp140 proteins differ markedly (30, 39, 65).
Specifically, the gp120 subunits of native-like trimers contain a
significantly higher percentage of oligomannose glycans as a result
of steric constraints on glycan-processing enzymes that are im-
posed by trimerization, which are similar to the constraints pres-
ent on virus-associated Env trimers (30, 39, 65). In contrast, the
same restrictions to glycan processing do not apply to the splayed-
out, dissociated subunits of the nonnative uncleaved gp140s,
which accordingly contain more highly processed glycans (39, 65).
Here, we performed similar glycan composition analyses on the
92UG037.8 and CZA97.012 SOSIP.664-His and gp140UNC-Fd-
His proteins (Table 2 and Fig. 10). As in the above studies, the
SOSIP.664-His trimers were purified by the PGT145 or PGT151
bNAb columns followed by SEC, and the gp140UNC-Fd-His pro-
teins were purified by Ni-NTA/SEC. Compared to the two
uncleaved gp140 proteins, the gp120 subunits of the two
SOSIP.664-His trimers had a greater oligomannose content,
which is consistent with earlier reports (30, 39, 65). The glycans
on the gp41ECTO subunits were more highly processed than on
their gp120 counterparts, again as reported previously for Env
proteins of other genotypes (39).
Disulfide bond formation in CZA97.012 SOSIP.664-His and
gp140UNC-Fd-His proteins. The gp120 proteins from most
HIV-1 isolates contain nine intermolecular disulfide bonds that
must form for the protein to fold and remain in a native confor-
mation. However, it was reported several years ago that gp120
monomers and uncleaved gp140 proteins contain inappropriate
intramolecular disulfide bonds (53–55, 74). Thus, in at least some
fraction of the total population of Env proteins, some Cys residues
can pair incorrectly and create nonnative proteins, with the V1V2
loop structure being particularly vulnerable to disulfide bond
scrambling. In addition, aberrant disulfides can lead to formation
of intermolecular disulfide bonds that cross-link the gp120 sub-
FIG 9 Conformational flexibility of SOSIP.664-His and gp140UNC-Fd-His
proteins. Deuterium uptake plots are shown for selected peptides from the
following purified Env proteins: BG505 SOSIP.664 (gray), 92UG037.8 gp120
(orange), 92UG037.8 SOSIP.664-His (red), CZA97.012 SOSIP.664-His
(blue), 92UG037.8 gp140UNC-Fd-His (green), and CZA97.012 gp140UNC-Fd-
His (purple). The position of each peptide is shown on the crystal structure of
the BG505 SOSIP.664 trimer (PDB accession no. 4TVP) on the top, with
sequence positions shown in parentheses (relative to HXB2 numbering) in the
bottom right-hand corner of each graph. Error bars show the standard devia-
tions from duplicate measurements, which in most cases are too small to see.
The tetrapeptide (PPPI) was added to each sample to ensure that exchange
conditions were identical among all samples compared. The 92UG037.8 and
CZA97.012 SOSIP.664-His trimers were purified by the PGT145/SEC and
PGT151/SEC methods, respectively, and the two gp140UNC-Fd-His proteins
were purified via Ni-NTA/SEC. The data for the BG505 SOSIP.664 and
92UG037.8 gp120 proteins were derived from prior reports (41, 48).
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units within a gp140 protein or cause these proteins to oligomerize
and aggregate (48, 71, 75–77; E. P. Go, A. Cupo, R. P. Ringe, P.
Pugach, J. P. Moore, and H. Desaire, unpublished results). As an
example of the latter problem, we show that the higher-MW gel
bands that are visible in preparations of purified 92UG037.8 and
CZA97.012 gp140UNC-Fd-His proteins are DTT sensitive and,
hence, contain disulfide-linked components (Fig. 4B).
Recently, it has been found that native-like BG505 and B41
SOSIP.664 trimers are almost entirely free of scrambled disulfide
bonds (Go et al., unpublished). These trimers provided a frame of
reference that allowed the estimation of the scrambled disulfide
bond content of the corresponding uncleaved gp140s to be in the
20 to 80% range; in other words, 20 to 80% of the gp120 subunits
in uncleaved gp140s are aberrantly folded (Go et al., unpub-
lished). Here, we conducted similar analyses of the disulfide
bond formation in the PGT151/SEC-purified, native-like
CZA97.012 SOSIP.664-His trimer and the Ni-NTA/SEC-puri-
fied gp140UNC-Fd-His protein (Table 3). We also analyzed
CZA97.012 SOSIP.664-His trimers purified by lectin/SEC and
found that 50% of the trimers in this preparation adopt na-
tive configurations when viewed by EM, compared to 95%
for the PGT151/SEC-purified preparation (Fig. 2A).
The canonical disulfide-bonded peptides were detected in each
of the three CZA97.012 gp140 populations, which is consistent
with several prior reports on various gp120 and gp140 proteins
(53–55, 74). However, aberrant forms were also detected (Table
3). The gp140UNC-Fd-His protein contained multiple aberrant di-
sulfide bonds affecting the N-terminal region of gp120, which
emulates previous results for a different preparation of the same
protein (54). In contrast, the SOSIP.664-His trimers contained
markedly few aberrant disulfide bonds; in particular, the PGT151/
SEC-purified, fully native trimer population was almost com-
pletely free of aberrant disulfide bonds, which implies that when
these entities are present, they are associated with the nonnative
subpopulation of Env trimers (Table 3). Overall, the mass spec-
trometry signals indicate that the abundance of aberrant disulfide
bonds in the PGT151/SEC-purified CZA97.012 SOSIP.664 trim-
ers is 10- to 100-fold lower than in the corresponding gp140UNC-
Fd-His protein. Even when the SOSIP.664 trimers were purified
by lectin/SEC, and hence only 50% native-like, they contained
fewer aberrant disulfide bonds than the gp140UNC-Fd-His protein
did (Table 3).
Creation of native-like uncleaved gp140 proteins. Two recent
studies report uncleaved gp140s that can adopt native-like config-
urations, at least in some genotypes, provided a flexible linker of
10 to 20 residues is introduced between the gp120 and gp41ECTO
subunits (3, 7). The appearance of these single-chain gp140 (sc-
gp140) or native flexibly linked gp140 (NFL-gp140) proteins is
TABLE 2 Glycan composition of 92UG037.8 and CZA97.012
SOSIP.664-His and gp140UNC-Fd-His proteins
HIV-1 isolate or
genotype and proteinb
Glycan composition (% of total glycans)a





gp140UNC-Fd-His 10 4 7 9 7 37
SOSIP.664-His gp120 7 7 11 21 20 65
SOSIP.664-His gp41 5 5 4 1 0 16
92UG037.8
gp140UNC-Fd-His 10 3 6 13 13 46
SOSIP.664-His gp120 14 6 9 14 27 72
SOSIP.664-His gp41 6 4 3 0 0 13
BG505
WT.SEKS gp140* 6 5 8 12 11 42
SOSIP.664 gp120* 4 4 6 15 34 63
SOSIP.664 gp41* 6 9 12 5 2 34
a The data represent the abundance (as a percentage of total glycans) of the
oligomannose structures (Man5–9GlcNAc2; indicated as M5 to M9), individually and in
total, for each Env protein analyzed. The remaining glycans are of the complex and
hybrid type, similar to what is described in more detail elsewhere for other, similar Env
proteins (39). The 92UG037.8 and CZA97.012 gp140UNC-Fd-His proteins were purified
by Ni-NTA/SEC, and the values presented are for the entire gp140 protein (i.e., gp120
plus gp41ECTO), as it was not possible to separate the individual subunits. The
92UG037.8 SOSIP.664-His trimers were purified by PGT145/SEC, and the CZA97.012
SOSIP.664-His trimers were purified by PGT151/SEC. For these trimers, values are also
presented for the individual gp120 and gp41ECTO subunits, which were separated for
analysis on a reducing SDS-polyacrylamide gel.
b For comparison, data derived from BG505 Env proteins and published elsewhere (39)
are also shown (the proteins are indicated by an asterisk). WT.SEKS is an uncleaved,
nonnative gp140 protein similar to gp140UNC-Fd-His but lacking the Fd and His
domains (19). Both BG505 Env proteins were expressed in 293T cells and purified by
2G12/SEC.
FIG 10 Glycan composition of SOSIP.664-His and gp140UNC-Fd-His pro-
teins. HILIC-UPLC chromatograms of fluorescently labeled N-linked glycans
released from 92UG037.8 and CZA97.012 SOSIP.664-His and gp140UNC-Fd-
His proteins, respectively, purified by the bNAb/SEC and Ni-NTA/SEC meth-
ods. The Foldon sequence present in the gp140UNC-Fd-His proteins does not
contain any canonical NXT or NXS motifs, so it is highly unlikely to be glyco-
sylated. Glycans were released from reducing SDS-polyacrylamide gel bands
using PNGase F. Peaks corresponding to oligomannose glycans (Man5–9Gl-
cNAc2) are colored in shades of green; the remaining peaks (gray) correspond
to complex and hybrid-type glycans. Peak areas (as a percentage of total gly-
cans) are recorded as numerical values in the associated pie charts and should
be consulted to obtain a quantitative estimate of the differences in the glycan
contents of the comparator proteins. Glycan structures are depicted according
to the color scheme established by the Consortium for Functional Genomics
(http://www.functionalglycomics.org/): green circles for mannose and blue
squares for N-acetylglucosamine.
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broadly comparable to those of native-like SOSIP.664 trimers
when visualized by negative-stain EM. The flexible linker appears
to allow the gp120 and gp41ECTO subunits to associate properly,
which is not the case with the standard design of uncleaved gp140
(19). However, both the sc-gp140 and NFL-gp140 constructs also
include the I559P modification or similar substitutions in
gp41ECTO to prevent its transition to the postfusion, six-helix bun-
dle form. In the context of the sc-gp140 protein, introduction of
the SOS intersubunit disulfide bond confers additional structural
benefits (7). An earlier report on the use of a flexible linker be-
tween gp120 and gp41ECTO claims that the resulting uncleaved
92UG037.8 gp140-FL20 proteins are not only native-like but that
they are also indistinguishable from the standard gp140UNC-Fd-
His proteins. Unlike the sc-gp140 or NFL-gp140 trimers, the
gp140-FL20 construct does not include either the I559P or the
SOS intermolecular disulfide bond (42). As we have shown
above that the 92UG037.8 gp140UNC-Fd-His protein does not
form native-like trimers, we elected to study flexible linker-
containing variants that do or do not also incorporate the
I559P and SOS changes. The construct designs are shown sche-
matically in Fig. 1.
The 92UG037.8 gp140-FL20 proteins were expressed in 293F
cells and purified by the Ni-NTA/SEC method. The SEC profile
was similar to that of the 92UG037.8 gp140UNC-Fd-His protein,
with comparable quantities of aggregates and trimers present
(data not shown). Negative-stain EM analysis showed that
the gp140-FL20 proteins were indistinguishable from their
gp140UNC-Fd-His counterparts, with 95% of the images rep-
resenting nonnative, structurally aberrant entities (Fig. 11A).
SPR antigenicity studies with bNAbs to quaternary structure-
dependent or -specific epitopes confirmed the lack of native
trimers in the gp140-FL20 preparation. Thus, in contrast to the
strong binding of the F105 CD4bs non-NAb, the PG16,
PGT145, and 35O22 bNAbs were all nonreactive with the
gp140-FL20 proteins (Fig. 11B). Therefore, the addition of
the 20-residue flexible linker is not sufficient to convert the
92UG037.8 gp140UNC-Fd-His protein into a native-like trimer.
We next investigated the effect of adding the I559P substitu-
tion, alone or in combination with the SOS change, to create the
92UG037.8 gp140-FL20-IP and gp140-FL20-SOSIP constructs
(Fig. 1). The 293F cell-expressed proteins were purified by Ni-
NTA/SEC. Negative-stain EM imaging showed that 5% of the
TABLE 3 Aberrant disulfide-linked peptides derived from CZA97.012 Env proteinsa
a A checkmark indicates that the disulfide-linked peptide was confirmed to be present, and an x indicates that it was not detected. “Minor” indicates that
the peptide was identified but at a much lower abundance compared to that of the gp140UNC-Fd-His protein. “Trace” means that the abundance of the
peptide was 10- to 100-fold lower than that of the gp140UNC-Fd-His protein.
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gp140-FL20-IP proteins adopted a native-like conformation, with
the rest being nonnative, while for the gp140-FL20-SOSIP prepa-
ration, the native-like trimer percentage increased to the 20 to
30% range (Fig. 11A). When transfection supernatants contain-
ing gp140-FL20-IP and gp140-FL20-SOSIP proteins were
passed down a PGT145 positive-selection column, small pop-
ulations of fully native-like trimers could be recovered for EM
imaging (Fig. 11A). When a similar experiment was performed
using 92UG037.8 gp140UNC-Fd-His supernatants, too little
Env protein could be recovered from the PGT145 column for
EM analysis (data not shown).
The Ni-NTA/SEC-purified gp140-FL20-IP and gp140-FL20-
SOSIP proteins were also studied by SPR. The PG16, PGT145, and
35O22 bNAbs did not bind detectably better to the gp140-FL20-IP
proteins than to the unmodified gp140UNC-Fd-His proteins, indi-
cating that the 5% percentage of native-like trimers shown by
EM was too low to generate quantifiable binding signals in the SPR
assay. In contrast, all three of these quaternary structure-depen-
dent or -specific bNAbs bound detectably to the gp140-FL20-
SOSIP proteins, most notably for 35O22, with a corresponding
reduction in F105 binding (Fig. 11B). Thus, the 20 to 30% of
native-like trimers that were visible in EM images of the gp140-
FL20-SOSIP proteins also register as native-like structures
when their antigenicity was studied by SPR. When the PGT145-
purified gp140-FL20-SOSIP trimers were also analyzed by SPR,
the binding of the PGT145, PGT16, and 35O22 bNAbs to their
quaternary epitopes was increased, while binding of the F105
non-NAb was negligible (Fig. 11C). It was not possible to re-
cover enough gp140-FL20-IP trimers from the PGT145 col-
umn for SPR analysis.
We conclude that the I559P change has a minimally positive
effect on the structures of the uncleaved gp140-FL20 proteins and
FIG 11 EM and SPR analyses of variants of the 92UG037.8 gp140UNC-Fd-His proteins containing flexible linkers. The 92UG037.8 gp140-FL20-His,
gp140-FL20-IP-His, and gp140-FL20-SOSIP.664-His constructs are shown in Fig. 1. (A to C) The proteins were purified by the Ni-NTA/SEC method or
via a PGT145 bNAb affinity column as indicated and then analyzed by EM (A) or SPR (B and C). (A) The gp140-FL20-His proteins were purified by
Ni-NTA/SEC. Attempts to purify native-like trimers based on this construct via the PGT145 column did not yield sufficient protein for EM analysis. The
gp140-FL20-IP-His (middle row) and gp140-FL20-SOSIP-His (bottom row) proteins were purified by Ni-NTA/SEC or by the PGT145 affinity column;
compared to the Ni-NTA/SEC method, the recoveries of trimers from the PGT145 column were 5% and 25%, respectively. (B) SPR data are shown
for all three variants of the 92UG037.8 gp140-FL20-His construct, each purified by Ni-NTA/SEC. Each variant is depicted in a different color, as indicated.
The quaternary epitope-specific bNAbs PG16 and PGT145 (trimer apex) and 35O22 (gp120-gp41ECTO interface) serve as diagnostic antibodies for
assessing the native-like trimer content. The CD4bs non-NAb F105 was used to assess the nonnative Env content of the samples. (C) SPR data were derived
using gp140-FL20-SOSIP-His proteins purified either by Ni-NTA/SEC (green) or by a PGT145 affinity column (gray). The PGT145-purified SOSIP.664-
His trimer (blue) serves as a comparator for each test antibody.
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that the SOS intermolecular disulfide bond must also be present
to create a meaningful amount of native-like trimers of the
92UG037.8 genotype. However, even the resulting gp140-FL20-
SOSIP proteins are predominantly (70 to 80%) nonnative; the
residual native-like population can be rescued by positive selec-
tion on a PGT145 column. It should be noted that a similar find-
ing was made with the cleaved 92UG037.8 SOSIP.664-His trimers
without positive selection, although in that case, the native-like
trimer percentage was approximately twofold higher (50%)
(Fig. 2A and 11C).
DISCUSSION
We can draw several conclusions that are relevant to the design
and production of soluble Env trimers for structural and vaccine
studies. First, fully native-like soluble SOSIP.664 trimers can in
fact be derived from the 92UG037.8 and CZA97.012 clade A and
clade C env genes. In both cases (92UG037.8 and CZA97.012),
positive selection for native-like trimers on an affinity column
based on a quaternary structure-dependent bNAb (PGT145 and
PGT151, respectively) is required to yield a fully native-like trimer
preparation, as nonnative trimers are also present when other, less
selective purification methods are used. It may be possible to fur-
ther engineer these env sequences to allow a less selective purifica-
tion method, for example, a 2G12 column, to be used. The present
versions of the 92UG037.8 and CZA97.012 SOSIP.664 trimers are
fully closed, highly thermally stable and have antigenic properties
consistent with their native-like appearance when visualized by
negative-stain EM. These trimers therefore add to the repertoire
of such reagents that are now available for structural and immu-
nogenicity studies (6, 18, 28, 64).
We again found that the standard design of uncleaved gp140
proteins, in this case, those proteins including a Foldon sequence,
yields only nonnative structures as assessed by multiple tech-
niques (3, 7, 16, 19, 26, 30, 41). Thus, the 92UG037.8 and
CZA97.012 gp140UNC-Fd-His trimer fraction contains disulfide-
linked higher-MW aggregates that cannot be fully separated from
the nonnative trimers. EM images show that the latter are not true
trimers but are oligomeric proteins that contain three splayed-out
gp120 subunits linked to a central gp41ECTO core via the uncleaved
connecting peptide. The antigenicity data are also consistent with
the EM images; nonneutralizing epitopes are exposed on the un-
cleaved gp140s, but the binding sites for trimer-dependent
epitopes are absent. Accordingly, very strong correlations were
found between the binding of NAbs or the nonbinding of non-
NAbs to the SOSIP.664-His trimers in ELISAs, on the one hand,
and on the other hand, neutralization or the lack thereof for the
corresponding Env-pseudotyped viruses. In contrast, no correla-
tion was found when a similar analysis was conducted using the
gp140UNC-Fd-His proteins. The SOSIP.664-His trimers are there-
fore excellent antigenic mimics of functional Env spikes on vi-
ruses, but their uncleaved, disordered, and nonnative counter-
parts are not.
DSC analysis further reveals that the uncleaved gp140s have, in
effect, already lost their native structure prior to the initiation of
the melting curves. HDX-MS analysis shows that several regions
of the native-like SOSIP.664-His trimers that are involved in sec-
ondary structures and that are not solvent exposed behave very
differently when they are in the context of the gp140UNC-Fd-His
proteins. There, the same regions have become solvent accessible,
rather than being involved in secondary structural interactions
with other regions of the nonnative oligomers (41, 48). Raising
antibodies against such proteins may therefore benefit from the
application of new, recently described methods (78). The glycan
composition analysis further reinforces how the uncleaved gp140s
lack the steric constraints imposed when the gp120 subunits are
components of properly assembled trimers; accordingly, the
gp140UNC-Fd-His glycans are much more highly processed than
those on the native-like SOSIP.664-His trimers (39, 79). Finally,
the uncleaved CZA97.012 gp140 proteins contain a substantial
proportion of gp120 subunits with scrambled disulfide bonds,
particularly in the V1V2 region; the aberrant subunits further
contribute to the nonnative antigenicity and associated aberrant
structural and aggregation properties of these proteins. Based on
prior reports and our unpublished work, this problem is generic to
the standard design of uncleaved gp140s (e.g., CZA97.012 and
92UG037.8 gp140UNC-Fd-His), but it also affects gp120 mono-
mers of multiple genotypes (53–55, 74; Go et al., unpublished).
Moreover, the scrambling of disulfide bonds explains why the
uncleaved gp140s are prone to forming aggregated, higher-MW
forms; internally unpaired Cys residues are available to bond with
counterparts on a neighboring gp140 protein. In contrast, the op-
timally purified (PGT151/SEC), fully native-like CZA97.012
SOSIP.664-His trimers contained very few scrambled disulfide
bonds. The latter were, however, found in significant amounts in
the lectin/SEC-purified preparation of the same SOSIP.664-His
proteins, in which 50% of the EM images show nonnative trim-
ers. The inference is that, when disulfide bond scrambling occurs,
it is incompatible with the formation of a native-like structure,
probably because the aberrant gp120 subunits cannot pack prop-
erly into the trimer. This topic, and its full implications for Env
protein production, will be described more fully elsewhere (Go et
al., unpublished).
In all of the above-described assays, there are marked contrasts
between the nonnative 92UG037.8 and CZA97.012 gp140UNC-Fd-
His gp140s and the native-like SOSIP.664-His trimers. The expla-
nation is that the formation of native trimers excludes defective
gp120 subunits, creates epitopes for quaternary structure-depen-
dent bNAbs, while occluding those for non-NAbs, and imposes
steric constraints on glycan-processing enzymes (1, 8, 20, 22, 23,
39, 68). The various defects present in the 92UG037.8 and
CZA97.012 gp140UNC-Fd-His gp140s are in no way unique to
these genotypes, as they have been found in similar assays using
several other uncleaved gp140s and/or can be inferred from the
general biochemical properties of such proteins (e.g., the propen-
sity to form disulfide-linked aggregates or the limited reactivity
with trimer-specific bNAbs). As various uncleaved gp140s are be-
ing tested in or produced for human clinical trials, including pro-
teins based on the 92UG037.8 and CO6980v0c22 genotypes, there
are obvious and serious concerns about at least some of the un-
derlying hypotheses (2, 4, 5, 34, 36, 42).
Claims that uncleaved gp140s have native-like properties, in-
cluding the 92UG037.8 and CZA97.012 gp140UNC-Fd-His pro-
teins, are often based on misinterpretation of antigenicity assays,
particularly SPR assays (2, 5). In a commonly used SPR format,
the gp140s flow over antibodies immobilized on a chip, and a
binding reaction is detected. If the test antibody is a bNAb to a
quaternary structure-dependent epitope, for example, PGT145,
such a binding event is considered to show that the uncleaved
gp140 must be a native-like trimer. The interpretation flaw, how-
ever, is that the detection of a binding signal says nothing about
Design and Purification of Native-Like HIV-1 Trimers
December 2015 Volume 89 Number 23 jvi.asm.org 12205Journal of Virology
 on D
ecem









the proportion of the input gp140 proteins that express the
epitope; all of the gp140 molecules that do not bind the bNAb are
invisible in the assay. Thus, an uncleaved gp140 preparation in
which, say, 5% of the proteins form native-like trimers, might
register as PGT145 reactive in this format of an SPR assay. How-
ever, if the same gp140 preparation is used as an immunogen, the
bulk of the injected proteins (in this example, 95%) will not be
native-like trimers. Our preferred format for SPR involves immo-
bilizing Env proteins on the chip via a His tag and then using the
test antibodies in the solution phase. This method allows a precise
comparison to be performed between Env proteins of the same or
different design, because the same amounts of the comparators
can be immobilized. When we directly compared the SOSIP.664-
His and gp140UNC-Fd-His versions of the 92UG037.8 and
CZA97.012 Env proteins in this way, the differences were quanti-
tatively and visually obvious (Fig. 6). Thus, whatever low-level
binding of bNAbs, such as PGT145 or PGT151, is observed with
the uncleaved gp140s, it is dwarfed by the corresponding signals
derived from their native-like SOSIP.664-His counterparts. Here,
again, the antigenicity data are entirely consistent with multiple
other assays, including EM imaging.
Native-like uncleaved gp140 trimers can indeed be made, but
only when a flexible linker is inserted between the gp120 and
gp41ECTO subunits and the I559P change, at minimum, is also
present (3, 7). We can confirm those findings, as we have pro-
duced uncleaved, partially native-like trimers based on the
92UG037.8 genotype. To do so required not only the addition of
the flexible linker (in this case, of 20 residues) but also the I559P
change and the SOS intermolecular disulfide bond. The I559P
change had a detectable although very modest beneficial effect
when introduced along with the flexible linker, but the SOS bond
was also required to make useful quantities of native-like un-
cleaved trimers. In the context of the BG505 genotype, the I559P
change appears sufficient to confer native-like structure on a un-
cleaved gp140 containing a flexible linker (3). However, the
BG505 env sequence is particularly suited to forming native-like
trimers, and the quantitative influence of the I559P substitution
seems likely to be genotype dependent. It is clear that, by itself, the
20-residue flexible linker is insufficient to convert the nonnative
92UG037.8 gp140UNC-Fd-His protein into a native-like trimer.
Thus, the resulting 92UG037.8 gp140-FL20 trimer is clearly non-
native when viewed by EM, with antigenicity properties that are
consistent with its lack of native structure. Since we made this
construct according to the same design reported by Kovacs et
al., our findings clearly do not support the claims in that paper
that both the 92UG037.8 gp140UNC-Fd-His and gp140-FL20
proteins are native-like trimers (42). In fact, we conclude from
multiple types of biochemical and biophysical analyses that
neither protein is native-like. What is verifiable is the claim that
the 92UG037.8 gp140UNC-Fd-His and gp140-FL20 proteins
are, in effect, identical to one another. Our analyses show, how-
ever, that their resemblance is because they both form nonna-
tive trimers.
While the introduction of a flexible linker and SOSIP substitu-
tions allows recognizably native-like uncleaved trimers of the
92UG037.8 genotype to be made, they are present at only 20 to
30% of the total population unless they are enriched via a
PGT145 positive-selection column. The same applies to the
cleaved 92UG037.8 SOSIP.664-His trimers after 2G12/SEC pu-
rification, although in that case, the percentage of native-like
trimers was approximately twofold higher. Whether the
92UG037.8 SOSIP.664-His and gp140-FL20-SOSIP proteins
could be further engineered to allow purification of fully na-
tive-like trimers (i.e., of BG505 or B41 SOSIP.664 quality)
without positive selection remains to be determined.
The compendium of biophysical and biochemical analyses
presented here clearly delineates the requirements for producing
native-like HIV-1 Env trimers. While each and every assay has
limitations and individual data sets need to be carefully inter-
preted, the combination of several different techniques paints a
consistent picture of Env properties. We have noted, in several
instances, the potential problems that arise when certain tech-
niques are used in isolation to make what we have now shown are
unjustified conclusions about what constitutes a native-like
trimer (42). Additionally, as we have shown elsewhere and rein-
force here, negative-stain EM is a robust tool; the images that it
generates correlate extremely well with the antigenicity and bio-
physical properties of native-like trimers and nonnative gp140
proteins (18, 19, 28–30). Thus, while it is convenient to claim that
SOSIP mutations are responsible for conferring a degree of stabil-
ity on Env trimers that makes them uniquely amenable to EM
analysis (42), stability and homogeneity are exactly what is desir-
able and sought after in an Env immunogen (6, 80, 81). Moreover,
with the SOSIP.664 trimers, protein stability and homogeneity are
accompanied by strong antigenicity for bNAb epitopes and prom-
ising immunogenicity (18, 28, 29). Finally, we note that if the
uncleaved gp140s are truly so fragile that their structure is de-
stroyed by contact with a carbon surface (44), they may be prob-
lematic when used as immunogens. How would they behave when
they become coated with particulate adjuvants, such as alum, or
are exposed to adverse environments like animal or human tissue
that contain proteases? Whether or not uncleaved gp140 proteins
such as those based on the CZA97.012 and 92UG037.8 genotypes
are pursued as immunogens in human clinical trials, claims that
these proteins have a native-like structure and, by inference, may
be able to induce trimerization-influenced NAbs to tier 2 viruses,
are clearly not verifiable. The same concerns apply to other un-
cleaved gp140s of comparable designs that are also being pro-
duced for clinical trials, again on the basis that they mimic the
native structure of virion-associated Env (36, 82). A more appro-
priate rationale for the use of uncleaved gp140s may be their in-
duction of non-NAbs that are partially protective in a macaque
challenge model (83). Having said that, it is notable that non-
NAbs are clearly very substantially less effective than bNAbs at
conferring protection in macaque passive transfer experiments
(84–86).
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